GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Japan Tissue Engineering Co Ltd (TSE:7774) » Definitions » Other Operating Expense

Japan Tissue Engineering Co (TSE:7774) Other Operating Expense : 円1,546 Mil (TTM As of Sep. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Japan Tissue Engineering Co Other Operating Expense?

Japan Tissue Engineering Co's Other Operating Expense for the three months ended in Sep. 2024 was 円0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 was 円1,546 Mil.

Japan Tissue Engineering Co's quarterly Other Operating Expense declined from Dec. 2023 (円395 Mil) to Mar. 2024 (円316 Mil) and declined from Mar. 2024 (円316 Mil) to Sep. 2024 (円0 Mil).

Japan Tissue Engineering Co's annual Other Operating Expense increased from Mar. 2022 (円1,076 Mil) to Mar. 2023 (円1,198 Mil) but then declined from Mar. 2023 (円1,198 Mil) to Mar. 2024 (円1,076 Mil).


Japan Tissue Engineering Co Other Operating Expense Historical Data

The historical data trend for Japan Tissue Engineering Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Japan Tissue Engineering Co Other Operating Expense Chart

Japan Tissue Engineering Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,021.63 996.82 1,075.94 1,197.76 1,076.14

Japan Tissue Engineering Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 446.14 389.32 395.04 315.63 -

Japan Tissue Engineering Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,546 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Japan Tissue Engineering Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Japan Tissue Engineering Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Japan Tissue Engineering Co Business Description

Traded in Other Exchanges
N/A
Address
6-209-1 Miyakitadori, Gamagori, Aichi, JPN, 443-0022
Japan Tissue Engineering Co Ltd is a bio-venture enterprise. It is engaged in the development, manufacture, and sale of tissue-engineered medical products and related products. It operates through the Regenerative Medicine, and Research and Development support business segments. The main business goal is to use autologous culturing techniques to develop tissue-engineered medical products and then to manufacture and sell these same tissue-engineered products to medical institutions for medical treatment. The company's tissue-engineered medical products are used in autologous transplant cases, where living cells are taken from the actual patient himself, cultured and then transplanted back to that same patient.

Japan Tissue Engineering Co Headlines

No Headlines